missing translation for 'onlineSavingsMsg'
Läs mer
Läs mer
Levetiracetam, MedChemExpress
Description
Levetiracetam, an antiepileptic agent, binds the synaptic vesicle protein SV2A. Levetiracetam enhances Temozolomide effect on glioblastoma stem cell proliferation and apoptosis. Levetiracetam modulates HDAC levels ultimately silencing MGMT, thus increasing Temozolomide effectiveness. A chemosensitizer agent.
Specifications
Specifications
| Kemiskt namn eller material | Levetiracetam |
| CAS | 102767-28-2 |
| Färg | White |
| Anteckningar om renhetsgrad | Research |
| Kvantitet | 500 mg |
| Synonym | UCB L059 |
| Löslighetsinformation | H2O : ≥ 85 mg/mL (499.38 mM) ∣DMSO : ≥ 85 mg/mL (499.38 mM) |
| LEDER | NC([C@@H](N(CCC1)C1=O)CC)=O |
| Molekylvikt (g/mol) | 170.21 |
| Procent renhet | 99.21% |
| Show More |
Research purposes only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?